Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

May 2023; Volume 43,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Aburatani, HIROYUKI

    1. You have access
      Tumor DNA in Peritoneal Lavage as a Novel Biomarker for Predicting Peritoneal Recurrence in Patients With Gastric Cancer
      NORIO YUKAWA, TAKESHI YAMADA, TORU AOYAMA, TEKKAN WOO, KOJI UEDA, AKIHISA MASTUDA, KENTARO HARA, KEISUKE KAZAMA, HIROSHI TAMAGAWA, TSUTOMU SATO, TAKASHI OSHIMA, AKIHIRO SUZUKI, HIROYUKI ABURATANI, SHUMPEI ISHIKAWA, AYA SAITO, MUNETAKA MASUDA, HIROSHI YOSHIDA and YASUSHI RINO
      Anticancer Research May 2023, 43 (5) 2069-2076; DOI: https://doi.org/10.21873/anticanres.16367
  2. Adachi, EISUKE

    1. You have access
      Survival Benefits of Laparoscopic Gastrectomy in Elderly Patients With Gastric Cancer: Focusing on Preoperative Nutritional and Inflammatory Status
      SHUHEI ITO, KIPPEI OHGAKI, TETSURO KAWAZOE, SHOTA SATO, SHUNJI IKEDA, KEISEI KAKIZOE, HUANLIN WANG, TOSHIHIKO NAKAMURA, SHINICHIRO MAEHARA, EISUKE ADACHI, YOICHI IKEDA and YOSHIHIKO MAEHARA
      Anticancer Research May 2023, 43 (5) 2055-2067; DOI: https://doi.org/10.21873/anticanres.16366
  3. Ahn, SANGJEONG

    1. You have access
      Epithelial-mesenchymal Transition Factor and Its Association With Mammographic Density and Breast Cancer Prognosis
      EUN YOUNG KIM and SANGJEONG AHN
      Anticancer Research May 2023, 43 (5) 2281-2292; DOI: https://doi.org/10.21873/anticanres.16392
  4. Ahrend, HANNES

    1. Open Access
      Reinforcement of the Tumor Suppressing Properties of microRNA-1 by Substitution at the C2′ Position of Varying Ribose Residues in Chemically Synthesized microRNA-1 Molecules
      HANNES AHREND, BETTINA APPEL, LISA JUNG, SABINE MÜLLER and MATTHIAS B. STOPE
      Anticancer Research May 2023, 43 (5) 1909-1918; DOI: https://doi.org/10.21873/anticanres.16350
  5. Aizawa, RIHITO

    1. You have access
      Efficacy and Tolerability of Second-line Pembrolizumab With Radiation Therapy in Advanced Urothelial Carcinoma
      TAKESHI SANO, RIHITO AIZAWA, KATSUHIRO ITO, KIYONAO NAKAMURA, TAKASHI OGATA, MASASHI TAKEDA, AKIHIRO HAMADA, TAKASHI MATSUOKA, JIN KONO, YUKI KITA, KIMIHIKO MASUI, TAKAYUKI GOTO, ATSURO SAWADA, SHUSUKE AKAMATSU, OSAMU OGAWA, TAKASHI MIZOWAKI and TAKASHI KOBAYASHI
      Anticancer Research May 2023, 43 (5) 2119-2126; DOI: https://doi.org/10.21873/anticanres.16373
  6. Ajiki, TETSUO

    1. You have access
      Prognostic Impact of Malnutrition Diagnosed by the GLIM Criteria for Resected Extrahepatic Cholangiocarcinoma
      YUKI OKAZOE, HIROAKI YANAGIMOTO, DAISUKE TSUGAWA, MASAYUKI AKITA, RIKI ASAKURA, SATOSHI OMIYA, TAKESHI URADE, YOSHIHIDE NANNO, KENJI FUKUSHIMA, HIDETOSHI GON, SHOHEI KOMATSU, KAORI KURAMITSU, TADAHIRO GOTO, SADAKI ASARI, HIROCHIKA TOYAMA, MASAHIRO KIDO, TETSUO AJIKI and TAKUMI FUKUMOTO
      Anticancer Research May 2023, 43 (5) 2299-2308; DOI: https://doi.org/10.21873/anticanres.16394
  7. Akamatsu, SHUSUKE

    1. You have access
      Efficacy and Tolerability of Second-line Pembrolizumab With Radiation Therapy in Advanced Urothelial Carcinoma
      TAKESHI SANO, RIHITO AIZAWA, KATSUHIRO ITO, KIYONAO NAKAMURA, TAKASHI OGATA, MASASHI TAKEDA, AKIHIRO HAMADA, TAKASHI MATSUOKA, JIN KONO, YUKI KITA, KIMIHIKO MASUI, TAKAYUKI GOTO, ATSURO SAWADA, SHUSUKE AKAMATSU, OSAMU OGAWA, TAKASHI MIZOWAKI and TAKASHI KOBAYASHI
      Anticancer Research May 2023, 43 (5) 2119-2126; DOI: https://doi.org/10.21873/anticanres.16373
  8. Akbarpour, FERRE

    1. You have access
      Nowarta110 Topical Versus Placebo for the Treatment of Plantar Warts: A Phase I/II Randomized Controlled Clinical Trial
      MAHKAMEH YOUSEFPOUR, IRAJ ZAMANIAN, FERRE AKBARPOUR, WILLIAM H. FANG, BO HAN and BA X. HOANG
      Anticancer Research May 2023, 43 (5) 2025-2030; DOI: https://doi.org/10.21873/anticanres.16363
  9. Akita, MASAYUKI

    1. You have access
      Prognostic Impact of Malnutrition Diagnosed by the GLIM Criteria for Resected Extrahepatic Cholangiocarcinoma
      YUKI OKAZOE, HIROAKI YANAGIMOTO, DAISUKE TSUGAWA, MASAYUKI AKITA, RIKI ASAKURA, SATOSHI OMIYA, TAKESHI URADE, YOSHIHIDE NANNO, KENJI FUKUSHIMA, HIDETOSHI GON, SHOHEI KOMATSU, KAORI KURAMITSU, TADAHIRO GOTO, SADAKI ASARI, HIROCHIKA TOYAMA, MASAHIRO KIDO, TETSUO AJIKI and TAKUMI FUKUMOTO
      Anticancer Research May 2023, 43 (5) 2299-2308; DOI: https://doi.org/10.21873/anticanres.16394
  10. Al-salool, AHMED

    1. You have access
      Emotional Distress in Head-and-neck Cancer Patients Scheduled for Chemoradiation or Radiotherapy Alone
      AHMED AL-SALOOL, TAMER SOROR, NATHAN Y. YU, CHRISTIAN IDEL, KARL L. BRUCHHAGE, SAMER G. HAKIM and DIRK RADES
      Anticancer Research May 2023, 43 (5) 2227-2233; DOI: https://doi.org/10.21873/anticanres.16386
    2. Open Access
      Prevalence and Risk Factors of Emotional Distress in Patients With Prostate Cancer Assigned to External-beam Radiotherapy With or Without High-dose Rate Brachytherapy
      AHMED AL-SALOOL, TAMER SOROR, NATHAN Y. YU and DIRK RADES
      Anticancer Research May 2023, 43 (5) 2103-2109; DOI: https://doi.org/10.21873/anticanres.16371
    3. Open Access
      Prevalence of and Risk Factors for Emotional Distress in Patients Undergoing Radiotherapy for Lung Cancer
      DIRK RADES, AHMED AL-SALOOL, SABINE BOHNET and NATHAN Y. YU
      Anticancer Research May 2023, 43 (5) 2111-2118; DOI: https://doi.org/10.21873/anticanres.16372
« Previous (Pages : 1 2 3 4 5 6 ... 50) Next »
Back to top
PreviousNext

In this issue

Anticancer Research: 43 (5)
Anticancer Research
Vol. 43, Issue 5
May 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • The Novel Use of IL-28 as an Effective Radiosensitizer in Pancreatic Cancer
  • Somatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing
  • Dimethyl Fumarate Suppresses the Proliferation of HTLV-1-infected T Cells by Inhibiting CBM Complex-triggered NF-GraphicB Signaling
  • Reinforcement of the Tumor Suppressing Properties of microRNA-1 by Substitution at the C2′ Position of Varying Ribose Residues in Chemically Synthesized microRNA-1 Molecules
  • A Phase I/II Investigation of Safety and Efficacy of Nivolumab and nab-Sirolimus in Patients With a Variety of Tumors With Genetic Mutations in the mTOR Pathway
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire